Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT05242484




Registration number
NCT05242484
Ethics application status
Date submitted
15/02/2022
Date registered
16/02/2022
Date last updated
31/10/2024

Titles & IDs
Public title
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Scientific title
A Phase 2b Randomized, Double-blind, Active-and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Secondary ID [1] 0 0
78934804UCO2001
Secondary ID [2] 0 0
CR109179
Universal Trial Number (UTN)
Trial acronym
DUET-UC
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Colitis, Ulcerative 0 0
Condition category
Condition code
Oral and Gastrointestinal 0 0 0 0
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Inflammatory and Immune System 0 0 0 0
Other inflammatory or immune system disorders
Oral and Gastrointestinal 0 0 0 0
Inflammatory bowel disease

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Other - Guselkumab
Treatment: Other - Golimumab
Treatment: Other - JNJ-78934804
Treatment: Drugs - Placebo

Placebo comparator: Group 1: Placebo - Participants will receive placebo subcutaneously (SC). All participants who meet inadequate response criteria will be escalated to an active treatment. Participants who are eligible and willing to continue the study intervention that they are receiving at Week 44 may enter the long-term extension.

Experimental: Group 2: Guselkumab - Participants will receive guselkumab dose regimen 1 SC. All participants who meet inadequate response criteria will be escalated to an active treatment. Participants who are eligible and willing to continue the study intervention that they are receiving at Week 44 may enter the long-term extension.

Experimental: Group 3: Golimumab - Participants will receive golimumab dose regimen 1 SC. All participants who meet inadequate response criteria will be escalated to an active treatment. Participants who are eligible and willing to continue the study intervention that they are receiving at Week 44 may enter the long-term extension.

Experimental: Group 4: JNJ-78934804 (High-dose) - Participants will receive JNJ-78934804 dose regimen 1 SC. All participants who meet inadequate response criteria will be escalated to an active treatment. Participants who are eligible and willing to continue the study intervention that they are receiving at Week 44 may enter the long-term extension.

Experimental: Group 5: JNJ-78934804 (Mid-dose) - Participants will receive JNJ-78934804 dose regimen 2 SC. All participants who meet inadequate response criteria will be escalated to an active treatment. Participants who are eligible and willing to continue the study intervention that they are receiving at Week 44 may enter the long-term extension.

Experimental: Group 6: JNJ-78934804 (Low-dose) - Participants will receive JNJ-78934804 dose regimen 3 SC. All participants who meet inadequate response criteria will be escalated to an active treatment. Participants who are eligible and willing to continue the study intervention that they are receiving at Week 44 may enter the long-term extension.


Treatment: Other: Guselkumab
Guselkumab will be administered as subcutaneous injection.

Treatment: Other: Golimumab
Golimumab will be administered as subcutaneous injection.

Treatment: Other: JNJ-78934804
JNJ-78934804 will be administered subcutaneously as per defined regimen.

Treatment: Drugs: Placebo
Placebo will be administered as subcutaneous injection.
Intervention code [1] 0 0
Treatment: Other
Intervention code [2] 0 0
Treatment: Drugs
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Percentage of Participants with Clinical Remission at Week 48
Timepoint [1] 0 0
Week 48
Secondary outcome [1] 0 0
Percentage of Participants with Endoscopic Improvement at Week 48
Timepoint [1] 0 0
Week 48
Secondary outcome [2] 0 0
Percentage of Participants with Corticosteroid-free Clinical Remission at Week 48
Timepoint [2] 0 0
Week 48
Secondary outcome [3] 0 0
Percentage of Participants with Symptomatic Remission at Week 48
Timepoint [3] 0 0
Week 48
Secondary outcome [4] 0 0
Percentage of Participants with Combination of Histological Remission and Endoscopic Improvement at Week 48
Timepoint [4] 0 0
Week 48
Secondary outcome [5] 0 0
Secondary Comparison: Percentage of Participants with Clinical Remission at Week 48
Timepoint [5] 0 0
Week 48
Secondary outcome [6] 0 0
Percentage of Participants with Adverse Events (AEs)
Timepoint [6] 0 0
Up to Week 48
Secondary outcome [7] 0 0
Percentage of Participants with Serious Adverse Events (SAEs)
Timepoint [7] 0 0
Up to Week 48
Secondary outcome [8] 0 0
Laboratory Parameters Over Time
Timepoint [8] 0 0
Up to Week 48
Secondary outcome [9] 0 0
Vital Signs Parameters Over Time
Timepoint [9] 0 0
Up to Week 48
Secondary outcome [10] 0 0
Suicidal Ideation Assessment Using Columbia Suicide Severity Rating Scale (C-SSRS) Score
Timepoint [10] 0 0
Up to Week 48
Secondary outcome [11] 0 0
Serum Concentrations of Guselkumab Over Time
Timepoint [11] 0 0
Up to Week 48
Secondary outcome [12] 0 0
Serum Concentrations of Golimumab Over Time
Timepoint [12] 0 0
Up to Week 48
Secondary outcome [13] 0 0
Percentage of Participants with Antibodies to Guselkumab
Timepoint [13] 0 0
Up to Week 48
Secondary outcome [14] 0 0
Titers of Antibodies to Guselkumab
Timepoint [14] 0 0
Up to Week 48
Secondary outcome [15] 0 0
Percentage of Participants with Antibodies to Golimumab
Timepoint [15] 0 0
Up to Week 48
Secondary outcome [16] 0 0
Titers of Antibodies to Golimumab
Timepoint [16] 0 0
Up to Week 48
Secondary outcome [17] 0 0
Percentage of Participants with Neutralizing Antibodies to Guselkumab
Timepoint [17] 0 0
Up to Week 48
Secondary outcome [18] 0 0
Percentage of Participants with Neutralizing Antibodies to Golimumab
Timepoint [18] 0 0
Up to Week 48

Eligibility
Key inclusion criteria
* Confirmed diagnosis of ulcerative colitis (UC) for at least 3 months prior to baseline
* Moderately to severely active UC as assessed by the modified Mayo score
* Demonstrated inadequate response, loss of response, or intolerance to at least one biologic or novel oral with biologic-like activity
* If female and of childbearing potential, must meet the contraception and reproduction requirements
Minimum age
18 Years
Maximum age
65 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Has severe extensive colitis as defined in the protocol
* Extent of inflammatory disease limited to the rectum
* Participants with current diagnosis of indeterminate colitis, microscopic colitis, ischemic colitis, or Crohn's disease (CD)
* Has a history of, or ongoing, chronic or recurrent infectious disease, including but not limited to, sinopulmonary infections, bronchiectasis, recurrent renal/urinary tract infections (example, pyelonephritis, cystitis), an open, draining, or infected skin wound, or an ulcer
* Currently has a malignancy or a history of malignancy within 5 years before screening (with the exception of nonmelanoma skin cancer or cervical carcinoma in situ that has been treated with no evidence of recurrence within 12 months of first dose of study intervention)

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s


The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Phase 2
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Active, not recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
19/09/2022
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
27/03/2029
Actual
Sample size
Target
Accrual to date
Final
577
Recruitment in Australia
Recruitment state(s)
Recruitment hospital [1] 0 0
Box Hill Hospital - Box Hill
Recruitment hospital [2] 0 0
Royal Prince Alfred Hospital - Camperdown
Recruitment hospital [3] 0 0
Monash Health, Monash Medical Centre - Clayton
Recruitment hospital [4] 0 0
Concord Hospital - Concord
Recruitment hospital [5] 0 0
Western Health - Footscray
Recruitment hospital [6] 0 0
Coastal Digestive Health - Maroochydore
Recruitment hospital [7] 0 0
Fiona Stanley Hospital - Murdoch
Recruitment hospital [8] 0 0
Royal Adelaide Hospital - North Terrace
Recruitment hospital [9] 0 0
Royal Melbourne Hospital - Parkville
Recruitment hospital [10] 0 0
The Alfred Hospital - Prahran
Recruitment hospital [11] 0 0
Mater Hospital Brisbane - South Brisbane
Recruitment postcode(s) [1] 0 0
3128 - Box Hill
Recruitment postcode(s) [2] 0 0
2050 - Camperdown
Recruitment postcode(s) [3] 0 0
3168 - Clayton
Recruitment postcode(s) [4] 0 0
2139 - Concord
Recruitment postcode(s) [5] 0 0
3011 - Footscray
Recruitment postcode(s) [6] 0 0
4558 - Maroochydore
Recruitment postcode(s) [7] 0 0
6150 - Murdoch
Recruitment postcode(s) [8] 0 0
5000 - North Terrace
Recruitment postcode(s) [9] 0 0
3050 - Parkville
Recruitment postcode(s) [10] 0 0
3004 - Prahran
Recruitment postcode(s) [11] 0 0
4101 - South Brisbane
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
California
Country [2] 0 0
United States of America
State/province [2] 0 0
Colorado
Country [3] 0 0
United States of America
State/province [3] 0 0
Connecticut
Country [4] 0 0
United States of America
State/province [4] 0 0
District of Columbia
Country [5] 0 0
United States of America
State/province [5] 0 0
Florida
Country [6] 0 0
United States of America
State/province [6] 0 0
Georgia
Country [7] 0 0
United States of America
State/province [7] 0 0
Idaho
Country [8] 0 0
United States of America
State/province [8] 0 0
Indiana
Country [9] 0 0
United States of America
State/province [9] 0 0
Kentucky
Country [10] 0 0
United States of America
State/province [10] 0 0
Maryland
Country [11] 0 0
United States of America
State/province [11] 0 0
Massachusetts
Country [12] 0 0
United States of America
State/province [12] 0 0
Michigan
Country [13] 0 0
United States of America
State/province [13] 0 0
Missouri
Country [14] 0 0
United States of America
State/province [14] 0 0
Nevada
Country [15] 0 0
United States of America
State/province [15] 0 0
New Hampshire
Country [16] 0 0
United States of America
State/province [16] 0 0
New York
Country [17] 0 0
United States of America
State/province [17] 0 0
North Carolina
Country [18] 0 0
United States of America
State/province [18] 0 0
Ohio
Country [19] 0 0
United States of America
State/province [19] 0 0
Pennsylvania
Country [20] 0 0
United States of America
State/province [20] 0 0
South Carolina
Country [21] 0 0
United States of America
State/province [21] 0 0
Tennessee
Country [22] 0 0
United States of America
State/province [22] 0 0
Texas
Country [23] 0 0
United States of America
State/province [23] 0 0
Virginia
Country [24] 0 0
United States of America
State/province [24] 0 0
Washington
Country [25] 0 0
United States of America
State/province [25] 0 0
Wisconsin
Country [26] 0 0
Argentina
State/province [26] 0 0
Ciudad Autonoma Buenos Aires
Country [27] 0 0
Argentina
State/province [27] 0 0
Ciudad Autonoma de Buenos Aires
Country [28] 0 0
Argentina
State/province [28] 0 0
Cordoba
Country [29] 0 0
Argentina
State/province [29] 0 0
Mar Del Plata
Country [30] 0 0
Argentina
State/province [30] 0 0
Rosario
Country [31] 0 0
Austria
State/province [31] 0 0
Salzburg
Country [32] 0 0
Austria
State/province [32] 0 0
Wels
Country [33] 0 0
Austria
State/province [33] 0 0
Wien
Country [34] 0 0
Belgium
State/province [34] 0 0
Bonheiden
Country [35] 0 0
Belgium
State/province [35] 0 0
Brugge
Country [36] 0 0
Belgium
State/province [36] 0 0
Bruxelles
Country [37] 0 0
Belgium
State/province [37] 0 0
Gent
Country [38] 0 0
Belgium
State/province [38] 0 0
Leuven
Country [39] 0 0
Belgium
State/province [39] 0 0
Liege
Country [40] 0 0
Belgium
State/province [40] 0 0
Liège
Country [41] 0 0
Belgium
State/province [41] 0 0
Sint-Niklaas
Country [42] 0 0
Brazil
State/province [42] 0 0
Botucatu
Country [43] 0 0
Brazil
State/province [43] 0 0
Brasilia
Country [44] 0 0
Brazil
State/province [44] 0 0
Caxias Do Sul
Country [45] 0 0
Brazil
State/province [45] 0 0
Curitiba
Country [46] 0 0
Brazil
State/province [46] 0 0
Porto Alegre
Country [47] 0 0
Brazil
State/province [47] 0 0
Rio de Janeiro
Country [48] 0 0
Brazil
State/province [48] 0 0
Salvador
Country [49] 0 0
Brazil
State/province [49] 0 0
Santo Andre
Country [50] 0 0
Brazil
State/province [50] 0 0
Santos
Country [51] 0 0
Brazil
State/province [51] 0 0
Sao Paulo
Country [52] 0 0
Brazil
State/province [52] 0 0
São Paulo
Country [53] 0 0
Bulgaria
State/province [53] 0 0
Haskovo
Country [54] 0 0
Bulgaria
State/province [54] 0 0
Sliven
Country [55] 0 0
Bulgaria
State/province [55] 0 0
Sofia-Grad
Country [56] 0 0
Bulgaria
State/province [56] 0 0
Sofia
Country [57] 0 0
Bulgaria
State/province [57] 0 0
Veliko Tarnovo
Country [58] 0 0
Bulgaria
State/province [58] 0 0
Vratsa
Country [59] 0 0
Canada
State/province [59] 0 0
Alberta
Country [60] 0 0
Canada
State/province [60] 0 0
British Columbia
Country [61] 0 0
Canada
State/province [61] 0 0
Manitoba
Country [62] 0 0
Canada
State/province [62] 0 0
Nova Scotia
Country [63] 0 0
Canada
State/province [63] 0 0
Ontario
Country [64] 0 0
Canada
State/province [64] 0 0
Quebec
Country [65] 0 0
Canada
State/province [65] 0 0
Bridgewater
Country [66] 0 0
Canada
State/province [66] 0 0
Saguenay
Country [67] 0 0
Chile
State/province [67] 0 0
Concepcion
Country [68] 0 0
Chile
State/province [68] 0 0
Santiago
Country [69] 0 0
China
State/province [69] 0 0
Chaoyang
Country [70] 0 0
China
State/province [70] 0 0
Chengdu
Country [71] 0 0
China
State/province [71] 0 0
Hangzhou
Country [72] 0 0
China
State/province [72] 0 0
Jinhua
Country [73] 0 0
China
State/province [73] 0 0
Nanjing
Country [74] 0 0
China
State/province [74] 0 0
Wuhan
Country [75] 0 0
Croatia
State/province [75] 0 0
Bjelovar
Country [76] 0 0
Croatia
State/province [76] 0 0
Split
Country [77] 0 0
Croatia
State/province [77] 0 0
Zagreb
Country [78] 0 0
Czechia
State/province [78] 0 0
Brno
Country [79] 0 0
Czechia
State/province [79] 0 0
Praha 9
Country [80] 0 0
Denmark
State/province [80] 0 0
Aalborg
Country [81] 0 0
Denmark
State/province [81] 0 0
Aarhus
Country [82] 0 0
Denmark
State/province [82] 0 0
Copenhagen
Country [83] 0 0
Denmark
State/province [83] 0 0
Herlev
Country [84] 0 0
Denmark
State/province [84] 0 0
Odense
Country [85] 0 0
Estonia
State/province [85] 0 0
Tallinn
Country [86] 0 0
Estonia
State/province [86] 0 0
Tartu
Country [87] 0 0
France
State/province [87] 0 0
AMIENS cedex 1
Country [88] 0 0
France
State/province [88] 0 0
Colombes Cedex
Country [89] 0 0
France
State/province [89] 0 0
Créteil
Country [90] 0 0
France
State/province [90] 0 0
Grenoble
Country [91] 0 0
France
State/province [91] 0 0
La Roche sur Yon
Country [92] 0 0
France
State/province [92] 0 0
Lille
Country [93] 0 0
France
State/province [93] 0 0
Marseille
Country [94] 0 0
France
State/province [94] 0 0
Montpellier
Country [95] 0 0
France
State/province [95] 0 0
Neuilly-sur-Seine
Country [96] 0 0
France
State/province [96] 0 0
Nice cedex 03
Country [97] 0 0
France
State/province [97] 0 0
Nîmes
Country [98] 0 0
France
State/province [98] 0 0
Pessac
Country [99] 0 0
France
State/province [99] 0 0
Pierre Bénite
Country [100] 0 0
France
State/province [100] 0 0
Saint Etienne
Country [101] 0 0
France
State/province [101] 0 0
Toulouse cedex 09
Country [102] 0 0
France
State/province [102] 0 0
Vandoeuvre les Nancy
Country [103] 0 0
Germany
State/province [103] 0 0
Berlin-Karlshorst
Country [104] 0 0
Germany
State/province [104] 0 0
Berlin
Country [105] 0 0
Germany
State/province [105] 0 0
Dresden
Country [106] 0 0
Germany
State/province [106] 0 0
Erlangen
Country [107] 0 0
Germany
State/province [107] 0 0
Frankfurt/Main
Country [108] 0 0
Germany
State/province [108] 0 0
Frankfurt
Country [109] 0 0
Germany
State/province [109] 0 0
Freiburg
Country [110] 0 0
Germany
State/province [110] 0 0
Fulda
Country [111] 0 0
Germany
State/province [111] 0 0
Halle (Saale)
Country [112] 0 0
Germany
State/province [112] 0 0
Halle
Country [113] 0 0
Germany
State/province [113] 0 0
Hannover
Country [114] 0 0
Germany
State/province [114] 0 0
Heidelberg
Country [115] 0 0
Germany
State/province [115] 0 0
Jena
Country [116] 0 0
Germany
State/province [116] 0 0
Jerichow
Country [117] 0 0
Germany
State/province [117] 0 0
Leipzig
Country [118] 0 0
Germany
State/province [118] 0 0
Lueneburg
Country [119] 0 0
Germany
State/province [119] 0 0
Mannheim
Country [120] 0 0
Germany
State/province [120] 0 0
Minden
Country [121] 0 0
Germany
State/province [121] 0 0
Munich
Country [122] 0 0
Germany
State/province [122] 0 0
Munster
Country [123] 0 0
Germany
State/province [123] 0 0
Münster
Country [124] 0 0
Germany
State/province [124] 0 0
Nürtingen
Country [125] 0 0
Germany
State/province [125] 0 0
Pforzheim
Country [126] 0 0
Germany
State/province [126] 0 0
Saarbrücken
Country [127] 0 0
Germany
State/province [127] 0 0
Tübingen
Country [128] 0 0
Germany
State/province [128] 0 0
Ulm
Country [129] 0 0
Germany
State/province [129] 0 0
Wipperfürth
Country [130] 0 0
Germany
State/province [130] 0 0
Würzburg
Country [131] 0 0
Greece
State/province [131] 0 0
Athens
Country [132] 0 0
Greece
State/province [132] 0 0
Piraievs
Country [133] 0 0
Greece
State/province [133] 0 0
Thessaloniki
Country [134] 0 0
Hungary
State/province [134] 0 0
Budapest
Country [135] 0 0
Hungary
State/province [135] 0 0
Gyongyos
Country [136] 0 0
Hungary
State/province [136] 0 0
Szeged
Country [137] 0 0
Hungary
State/province [137] 0 0
Szombathely
Country [138] 0 0
India
State/province [138] 0 0
Bangalore
Country [139] 0 0
India
State/province [139] 0 0
Bhubaneswar
Country [140] 0 0
India
State/province [140] 0 0
Jaipur
Country [141] 0 0
India
State/province [141] 0 0
New Delhi
Country [142] 0 0
India
State/province [142] 0 0
Secunderabad
Country [143] 0 0
India
State/province [143] 0 0
Surat
Country [144] 0 0
Israel
State/province [144] 0 0
Afula
Country [145] 0 0
Israel
State/province [145] 0 0
Haifa
Country [146] 0 0
Israel
State/province [146] 0 0
Jerusalem
Country [147] 0 0
Israel
State/province [147] 0 0
Petah Tikva
Country [148] 0 0
Israel
State/province [148] 0 0
Rehovot
Country [149] 0 0
Israel
State/province [149] 0 0
Tel Aviv Yafo
Country [150] 0 0
Israel
State/province [150] 0 0
Tel Hashomer
Country [151] 0 0
Israel
State/province [151] 0 0
Tzrifin
Country [152] 0 0
Italy
State/province [152] 0 0
Bari
Country [153] 0 0
Italy
State/province [153] 0 0
Catania
Country [154] 0 0
Italy
State/province [154] 0 0
Messina
Country [155] 0 0
Italy
State/province [155] 0 0
Milano
Country [156] 0 0
Italy
State/province [156] 0 0
Monserrato
Country [157] 0 0
Italy
State/province [157] 0 0
Monza
Country [158] 0 0
Italy
State/province [158] 0 0
Negrar Di Valpolicella
Country [159] 0 0
Italy
State/province [159] 0 0
Palermo
Country [160] 0 0
Italy
State/province [160] 0 0
Roma
Country [161] 0 0
Italy
State/province [161] 0 0
Rozzano
Country [162] 0 0
Italy
State/province [162] 0 0
San Giovanni Rotondo
Country [163] 0 0
Japan
State/province [163] 0 0
Asahikawa
Country [164] 0 0
Japan
State/province [164] 0 0
Bunkyo Ku
Country [165] 0 0
Japan
State/province [165] 0 0
Chikushino
Country [166] 0 0
Japan
State/province [166] 0 0
Fukuoka-ken
Country [167] 0 0
Japan
State/province [167] 0 0
Gifu
Country [168] 0 0
Japan
State/province [168] 0 0
Hachioji
Country [169] 0 0
Japan
State/province [169] 0 0
Hamamatsu
Country [170] 0 0
Japan
State/province [170] 0 0
Hirosaki
Country [171] 0 0
Japan
State/province [171] 0 0
Isehara
Country [172] 0 0
Japan
State/province [172] 0 0
Kagoshima
Country [173] 0 0
Japan
State/province [173] 0 0
Kamakura
Country [174] 0 0
Japan
State/province [174] 0 0
Kanagawa
Country [175] 0 0
Japan
State/province [175] 0 0
Kashihara
Country [176] 0 0
Japan
State/province [176] 0 0
Kashiwa
Country [177] 0 0
Japan
State/province [177] 0 0
Kobe
Country [178] 0 0
Japan
State/province [178] 0 0
Kofu-Shi
Country [179] 0 0
Japan
State/province [179] 0 0
Kumamoto
Country [180] 0 0
Japan
State/province [180] 0 0
Kurume
Country [181] 0 0
Japan
State/province [181] 0 0
Kyoto
Country [182] 0 0
Japan
State/province [182] 0 0
Maebashi
Country [183] 0 0
Japan
State/province [183] 0 0
Minato-ku
Country [184] 0 0
Japan
State/province [184] 0 0
Mitaka
Country [185] 0 0
Japan
State/province [185] 0 0
Morioka
Country [186] 0 0
Japan
State/province [186] 0 0
Nagoya
Country [187] 0 0
Japan
State/province [187] 0 0
Nishinomiya
Country [188] 0 0
Japan
State/province [188] 0 0
Ogaki
Country [189] 0 0
Japan
State/province [189] 0 0
Oita
Country [190] 0 0
Japan
State/province [190] 0 0
Osaka-shi
Country [191] 0 0
Japan
State/province [191] 0 0
Osaka
Country [192] 0 0
Japan
State/province [192] 0 0
Sakura
Country [193] 0 0
Japan
State/province [193] 0 0
Sapporo Chuo-ku
Country [194] 0 0
Japan
State/province [194] 0 0
Sapporo
Country [195] 0 0
Japan
State/province [195] 0 0
Sumida ku
Country [196] 0 0
Japan
State/province [196] 0 0
Tokyo
Country [197] 0 0
Japan
State/province [197] 0 0
Tomakomai
Country [198] 0 0
Japan
State/province [198] 0 0
Toyama
Country [199] 0 0
Japan
State/province [199] 0 0
Toyota
Country [200] 0 0
Japan
State/province [200] 0 0
Tsukuba City
Country [201] 0 0
Japan
State/province [201] 0 0
Tsu
Country [202] 0 0
Japan
State/province [202] 0 0
Wakayama
Country [203] 0 0
Japan
State/province [203] 0 0
Yokohama
Country [204] 0 0
Jordan
State/province [204] 0 0
Amman
Country [205] 0 0
Jordan
State/province [205] 0 0
Irbid
Country [206] 0 0
Korea, Republic of
State/province [206] 0 0
Busan
Country [207] 0 0
Korea, Republic of
State/province [207] 0 0
Daegu
Country [208] 0 0
Korea, Republic of
State/province [208] 0 0
Gwangju
Country [209] 0 0
Korea, Republic of
State/province [209] 0 0
Gyeonggi-do
Country [210] 0 0
Korea, Republic of
State/province [210] 0 0
Hwaseong-si
Country [211] 0 0
Korea, Republic of
State/province [211] 0 0
Seoul
Country [212] 0 0
Korea, Republic of
State/province [212] 0 0
Suwon
Country [213] 0 0
Korea, Republic of
State/province [213] 0 0
Wonju, Gangwon-do
Country [214] 0 0
Netherlands
State/province [214] 0 0
Amsterdam
Country [215] 0 0
Netherlands
State/province [215] 0 0
Dordrecht
Country [216] 0 0
Netherlands
State/province [216] 0 0
Maastricht
Country [217] 0 0
Netherlands
State/province [217] 0 0
Rotterdam
Country [218] 0 0
Netherlands
State/province [218] 0 0
Utrecht
Country [219] 0 0
New Zealand
State/province [219] 0 0
Christchurch
Country [220] 0 0
New Zealand
State/province [220] 0 0
Dunedin
Country [221] 0 0
New Zealand
State/province [221] 0 0
Lower Hutt
Country [222] 0 0
New Zealand
State/province [222] 0 0
Wellington
Country [223] 0 0
Norway
State/province [223] 0 0
Alesund
Country [224] 0 0
Norway
State/province [224] 0 0
Gjettum
Country [225] 0 0
Norway
State/province [225] 0 0
Gjøvik
Country [226] 0 0
Norway
State/province [226] 0 0
Lørenskog
Country [227] 0 0
Norway
State/province [227] 0 0
Oslo
Country [228] 0 0
Norway
State/province [228] 0 0
Tromso
Country [229] 0 0
Poland
State/province [229] 0 0
Bydgoszcz
Country [230] 0 0
Poland
State/province [230] 0 0
Krakow
Country [231] 0 0
Poland
State/province [231] 0 0
Lodz
Country [232] 0 0
Poland
State/province [232] 0 0
Lublin
Country [233] 0 0
Poland
State/province [233] 0 0
Nowy Targ
Country [234] 0 0
Poland
State/province [234] 0 0
Olsztyn
Country [235] 0 0
Poland
State/province [235] 0 0
Poznan
Country [236] 0 0
Poland
State/province [236] 0 0
Rzeszow
Country [237] 0 0
Poland
State/province [237] 0 0
Sopot
Country [238] 0 0
Poland
State/province [238] 0 0
Szczecin
Country [239] 0 0
Poland
State/province [239] 0 0
Torun
Country [240] 0 0
Poland
State/province [240] 0 0
Warszawa
Country [241] 0 0
Poland
State/province [241] 0 0
Wloclawek
Country [242] 0 0
Poland
State/province [242] 0 0
Wroclaw
Country [243] 0 0
Poland
State/province [243] 0 0
Zamosc
Country [244] 0 0
Portugal
State/province [244] 0 0
Lisboa
Country [245] 0 0
Portugal
State/province [245] 0 0
Loures
Country [246] 0 0
Portugal
State/province [246] 0 0
Portimao
Country [247] 0 0
Portugal
State/province [247] 0 0
Santa Maria da Feira
Country [248] 0 0
Portugal
State/province [248] 0 0
Vila Nova de Gaia
Country [249] 0 0
Slovakia
State/province [249] 0 0
Banska Bystrica
Country [250] 0 0
Slovakia
State/province [250] 0 0
Bratislava
Country [251] 0 0
Slovakia
State/province [251] 0 0
Presov
Country [252] 0 0
Slovakia
State/province [252] 0 0
Vranov nad Toplou
Country [253] 0 0
Slovenia
State/province [253] 0 0
Celje
Country [254] 0 0
Slovenia
State/province [254] 0 0
Ljubljana
Country [255] 0 0
South Africa
State/province [255] 0 0
Benoni
Country [256] 0 0
South Africa
State/province [256] 0 0
Cape Town
Country [257] 0 0
South Africa
State/province [257] 0 0
Johannesburg
Country [258] 0 0
South Africa
State/province [258] 0 0
Pretoria
Country [259] 0 0
Spain
State/province [259] 0 0
Barcelona
Country [260] 0 0
Spain
State/province [260] 0 0
Madrid
Country [261] 0 0
Spain
State/province [261] 0 0
Pamplona
Country [262] 0 0
Spain
State/province [262] 0 0
Pontevedra
Country [263] 0 0
Spain
State/province [263] 0 0
Sabadell
Country [264] 0 0
Spain
State/province [264] 0 0
Santander
Country [265] 0 0
Spain
State/province [265] 0 0
Torrejón de Ardoz
Country [266] 0 0
Spain
State/province [266] 0 0
Vigo
Country [267] 0 0
Sweden
State/province [267] 0 0
Solna
Country [268] 0 0
Sweden
State/province [268] 0 0
Stockholm
Country [269] 0 0
Switzerland
State/province [269] 0 0
Basel
Country [270] 0 0
Switzerland
State/province [270] 0 0
Bern
Country [271] 0 0
Switzerland
State/province [271] 0 0
St. Gallen
Country [272] 0 0
Switzerland
State/province [272] 0 0
Zuerich
Country [273] 0 0
Taiwan
State/province [273] 0 0
Changhua
Country [274] 0 0
Taiwan
State/province [274] 0 0
Taichung
Country [275] 0 0
Taiwan
State/province [275] 0 0
Tainan
Country [276] 0 0
Taiwan
State/province [276] 0 0
Taipei
Country [277] 0 0
Taiwan
State/province [277] 0 0
Taoyuan
Country [278] 0 0
United Kingdom
State/province [278] 0 0
Belfast
Country [279] 0 0
United Kingdom
State/province [279] 0 0
Cambridge
Country [280] 0 0
United Kingdom
State/province [280] 0 0
Glasgow
Country [281] 0 0
United Kingdom
State/province [281] 0 0
High Wycombe
Country [282] 0 0
United Kingdom
State/province [282] 0 0
London
Country [283] 0 0
United Kingdom
State/province [283] 0 0
Oxford

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
Janssen Research & Development, LLC
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
The purpose of this study is to evaluate the efficacy and safety of JNJ-78934804 as compared to guselkumab and golimumab in participants with moderately to severely active ulcerative colitis who have had an inadequate initial response, loss of response, or intolerance to one or more approved advanced therapy.
Trial website
https://clinicaltrials.gov/study/NCT05242484
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Janssen Research & Development, LLC Clinical Trial
Address 0 0
Janssen Research & Development, LLC
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Study Contact
Address 0 0
Country 0 0
Phone 0 0
844-434-4210
Fax 0 0
Email 0 0
[email protected]
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/study/NCT05242484